Carl Sterritt
Director Ejecutivo en Phosphate Therapeutics Ltd. .
Perfil
Carl Sterritt is the founder of Shield Holdings AG and Shield Therapeutics Plc, both founded in 2008.
At Shield Holdings AG, he held the title of Chief Executive Officer & Director from 2011 to 2015.
At Shield Therapeutics Plc, he held the title of Chief Executive Officer & Executive Director from 2008 to 2020.
Currently, he is the Chief Executive Officer at Phosphate Therapeutics Ltd.
He previously held the title of Director-European Commercial Operations at Encysive Pharmaceuticals, Inc. and Senior Vice President-Commercial Development at United Therapeutics Corp.
Cargos activos de Carl Sterritt
| Empresas | Cargo | Inicio |
|---|---|---|
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Director Ejecutivo | - |
Antiguos cargos conocidos de Carl Sterritt.
| Empresas | Cargo | Fin |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Fundador | 22/04/2020 |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Carl Sterritt